Sign In
Buy AVDL
$21.64
+0 (+0%)
At Close: May 08, 2026
Alkermes: 'Buy' On Avadel Acquisition And Positive NT2 Data With Alixorexton
03:49pm, Friday, 19'th Jun 2026
Alkermes plc maintains a Buy rating, driven by the accretive Avadel Pharmaceuticals acquisition and strong pipeline progress. Company bolstered its hypersomnolence portfolio with LUMRYZ, which deliver
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Cross Above 200-Day Moving Average – What’s Next?
04:33am, Saturday, 21'st Feb 2026
Avadel Pharmaceuticals PLC. (NASDAQ: AVDL - Get Free Report) passed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $18.63 and trad
Form 8.3 - Avadel Pharmaceuticals plc
08:31am, Thursday, 12'th Feb 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
07:30am, Thursday, 12'th Feb 2026
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) (“Alkermes”) and Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“Avadel”) today announced Alkermes' completion of its acquisition of Avadel, a
Form 8.3 -Avadel Pharmaceuticals plc
08:31am, Wednesday, 11'th Feb 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing
04:05pm, Tuesday, 10'th Feb 2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
Form 8.3 -Avadel Pharmaceuticals plc
08:24am, Tuesday, 10'th Feb 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 -Avadel Pharmaceuticals plc
08:02am, Monday, 09'th Feb 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 -Avadel Pharmaceuticals plc
08:54am, Friday, 06'th Feb 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 -Avadel Pharmaceuticals plc
08:39am, Thursday, 05'th Feb 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 -Avadel Pharmaceuticals plc
08:41am, Wednesday, 04'th Feb 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 -Avadel Pharmaceuticals plc
09:20am, Tuesday, 03'rd Feb 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 -Avadel Pharmaceuticals plc
08:51am, Wednesday, 28'th Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 -Avadel Pharmaceuticals plc
08:44am, Tuesday, 27'th Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
Form 8.3 - Avadel Pharmaceuticals plc
08:36am, Monday, 26'th Jan 2026
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.
